3652 results for «303»
3652 results
Innovations in transcatheter tricuspid valve intervention - LIVE case
21 Nov 2023 – From PCR London Valves 2023
Consult this session to discover the new transcatheter treatment strategies, improve your understanding of the clinical indications for intervention, and appreciate the challenges and limitations of tricuspid valve imaging before and during the intervention.
- LIVE case: An 81-year-old woman with permanent AF presents a symptomatic torrential TR with right...
Key questions in aortic valve intervention - Anticoagulation after TAVI - when, and for whom?
21 Nov 2023 – From PCR London Valves 2023
Tune in to this session focused on post-TAVI anticoagulation, where the cases of three TAVI patients are explored. Analyze and determine the optimal antithrombotic strategy for each situation: the first patient in sinus rhythm, the second with atrial fibrillation, and the third with atrial fibrillation undergoing...
Rapid-fire - Nightmares in the cathlab - Part 1
19 Nov 2023 – From PCR London Valves 2023
Discover intriguing cases featured in the PCR London Valves 2023 course: learn about a rare malfunction in a Mitral TEER device, delve into the complexities surrounding a self-expanding valve TAVI where embolisation poses a threat towards the left ventricle, explore the challenges associated with TAVR in...
Mitral valve intervention in complex scenarios - Transcatheter mitral valve replacement - who are the eligible patients, and what are the available options?
21 Nov 2023 – From PCR London Valves 2023
This PCR London Valves 2023 session about mitral valve interventions seeks to address three key questions: identifying the ideal patient for Transcatheter Mitral Valve Implantation (TMVI), exploring treatment alternatives for ineligible patients, and discussing the prediction and management of left ventricular outflow tract obstruction. Watch video...
Rapid-fire - Challenging TAVI procedures - Part 1
19 Nov 2023 – From PCR London Valves 2023
Discover challenging TAVI procedures in this session, including: TAVI in a small aortic annulus with chimney stenting, TAVI with ACURATE Neo 2 and coronary protection in a horizontal aorta with low coronary height, simultaneous kissing balloon inflation technique for effective coronary protection during TAVI, and much...
Key questions in aortic valve intervention - How to navigate valve sequencing in younger patients?
21 Nov 2023 – From PCR London Valves 2023
What are the aspects to consider when treating younger patients? In this session, get both the interventional cardiologist's and the surgeon's perspective. What do we know and what do we need to know about valve sequencing and hemodynamics? What about CT planning and execution of redo-TAVI?...
Rapid-fire - Challenging tricuspid procedures
19 Nov 2023 – From PCR London Valves 2023
Discover challenging tricuspid procedures in this session: learn more about the struggle of recurrent heart failure in the presence of a left ventricular assist device, gain insights into single-stage percutaneous replacement of native pulmonary and tricuspid valves, navigate the complexities of managing bioprosthetic tricuspid stenosis post-cardiac...
Rapid-fire - Challenging mitral procedures - Part 2
19 Nov 2023 – From PCR London Valves 2023
Discover various challenging mitral procedures in this session: learn about the difficulties of MitraClip placement at A2/P2, explore the feasibility of treating large failed mitral annuloplasty rings with valve-in-ring replacement, witness innovative transcatheter edge-to-edge repair addressing severe mitral regurgitation, and more!
INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes
03 Sep 2024
Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.
Author
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications
22 Mar 2022
Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.
Author
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
29 Mar 2025
Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.
Author
Author
